Showing results (131-140 of 178) with videos related to
Sort By:
Pageof 18
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 12, 2012
Clinical benefit of response in chronic graft-versus-host diseaseYoshihiro Inamoto, Paul J Martin, Xiaoyu Chai, et al.Bone Marrow Transplantation|September 27, 2020
Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approachMasumi Ueda Oshima, Brenda M Sandmaier, Effie Petersdorf, et al.Bone Marrow Transplantation|January 30, 2021
Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committeeAkshay Sharma, Sherif M Badawy, Elizabeth M Suelzer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2022
Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host DiseaseMarie Bleakley, Alison Sehgal, Stuart Seropian, et al.Ophthalmology|December 14, 2011
Validation of measurement scales in ocular graft-versus-host diseaseYoshihiro Inamoto, Xiaoyu Chai, Brenda F Kurland, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 10, 2013
Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host diseaseJeanne Palmer, Kirsten Williams, Yoshihiro Inamoto, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 21, 2017
Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host DiseaseGeorge L Chen, Paul A Carpenter, Raewyn Broady, et al.Blood|August 5, 2004
Duration of immunosuppressive treatment for chronic graft-versus-host diseaseBetty L Stewart, Barry Storer, Jan Storek, et al.Blood|January 26, 2011
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteriaMary E D Flowers, Yoshihiro Inamoto, Paul A Carpenter, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 3, 2020
HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Nonmalignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant CyclophosphamideKanwaldeep K Mallhi, Meera A Srikanthan, Kelsey K Baker, et al.Pageof 18